Milestone Scientific, Inc. (MLSS) financial statements (2021 and earlier)

Company profile

Business Address 220 SOUTH ORANGE AVENUE
LIVINGSTON, NJ 07039
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments142134410
Cash and cash equivalents142134410
Receivables1224322
Inventory, net of allowances, customer advances and progress billings2223542
Inventory2223542
Deferred costs  011  
Advances on inventory purchases0111111
Other undisclosed current assets0100000
Total current assets:196612131216
Noncurrent Assets
Operating lease, right-of-use asset1 
Property, plant and equipment0000000
Long-term investments and receivables   1  1
Long-term investments      1
Accounts and financing receivable, after allowance for credit loss   1   
Intangible assets, net (including goodwill)0003111
Intangible assets, net (excluding goodwill)0003111
Other noncurrent assets0000000
Other undisclosed noncurrent assets     00
Total noncurrent assets:1014112
TOTAL ASSETS:207616141317
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1233441
Accounts payable0111321
Accrued liabilities111212 
Debt00     
Due to related parties0121   
Deferred revenue and credits21  
Contract with customer, liability0
Other undisclosed current liabilities1101  1
Total current liabilities:3557542
Noncurrent Liabilities
Long-term debt and lease obligation1      
Finance lease, liability0 
Operating lease, liability1 
Other undisclosed noncurrent liabilities(1)  1  0
Total noncurrent liabilities:1  1  0
Total liabilities:3558542
Stockholders' equity
Stockholders' equity attributable to parent, including:1622791015
Preferred stock  000  
Common stock0000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital118968887837978
Accumulated deficit(101)(94)(86)(79)(73)(67)(62)
Other undisclosed stockholders' equity attributable to parent     00
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)00(1)0
Total stockholders' equity:162289915
Other undisclosed liabilities and equity      (0)
TOTAL LIABILITIES AND EQUITY:207616141317

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues58101110910
Revenue, net1110910
Cost of revenue
(Cost of Goods and Services Sold)
(2)(3)(5)(4)(4)(3)(4)
Gross profit:4647667
Operating expenses(11)(10)(12)(12)(13)(10)(7)
Operating loss:(7)(4)(8)(5)(7)(3)(1)
Nonoperating income (expense)(0)(4)00(0)(0)(1)
Investment income, nonoperating (4)00000
Other nonoperating expense(0)(0)(0)(0)(0)(0) 
Interest and debt expense      (0)
Other undisclosed income from continuing operations before equity method investments, income taxes00     
Loss from continuing operations before equity method investments, income taxes:(7)(8)(8)(5)(7)(3)(2)
Income (loss) from equity method investments000(0)(1)(2) 
Other undisclosed income from continuing operations before income taxes      0
Loss from continuing operations before income taxes:(7)(8)(8)(5)(7)(6)(2)
Income tax expense (benefit)(0)(0)(0)(0)0(0)(0)
Loss before gain (loss) on sale of properties:(7)(8)(8)(5)(7)(6)(2)
Other undisclosed net income  0    
Net loss:(7)(8)(8)(5)(7)(6)(2)
Net income attributable to noncontrolling interest0000100
Net loss available to common stockholders, diluted:(7)(8)(7)(5)(6)(5)(2)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(7)(8)(8)(5)(7)(6)(2)
Comprehensive loss:(7)(8)(8)(5)(7)(6)(2)
Comprehensive income, net of tax, attributable to noncontrolling interest0000100
Comprehensive loss, net of tax, attributable to parent:(7)(8)(7)(5)(6)(5)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: